9781760232764 (ISBN)
http://nla.gov.au/nla.obj-3141635367
New South Wales. Ministry of Health, issuing body & Cancer Institute NSW, issuing body. (2022). International consensus guideline on anticancer drug dosing in kidney dysfunction (ADDIKD) Retrieved July 20, 2026, from http://nla.gov.au/nla.obj-3141635367
New South Wales. Ministry of Health, issuing body and Cancer Institute NSW, issuing body. International consensus guideline on anticancer drug dosing in kidney dysfunction (ADDIKD) St Leonards, NSW: NSW Ministry of Health : Cancer Institute NSW, 2022. Web. 20 July 2026 <http://nla.gov.au/nla.obj-3141635367>
New South Wales. Ministry of Health, issuing body & Cancer Institute NSW, issuing body. 2022, International consensus guideline on anticancer drug dosing in kidney dysfunction (ADDIKD) NSW Ministry of Health : Cancer Institute NSW, St Leonards, NSW viewed 20 July 2026 http://nla.gov.au/nla.obj-3141635367
{{Citation
| author1=New South Wales. Ministry of Health, issuing body.
| author2=Cancer Institute NSW, issuing body.
| title=International consensus guideline on anticancer drug dosing in kidney dysfunction (ADDIKD)
| year=2022
| section=1 online resource (295 pages)
| isbn=9781760232764
| location=St Leonards, NSW
| publisher=NSW Ministry of Health : Cancer Institute NSW
| url=http://nla.gov.au/nla.obj-3141635367
| id=nla.obj-3141635367
| access-date=20 July 2026
| via=Trove
}}
Citations are automatically generated and may require some modification to conform to exact standards.
In Copyright
You may order a copy or use the online copy for research or study; for other uses Contact us.
Copyright status may not be correct if data in the record is incomplete or inaccurate. Other access conditions may also apply.
For more information please see: Copyright in library collections.